logo
logo

Genetic Leap and Lilly Enter Collaboration to Accelerate Genetic Medicine Development with AI

Genetic Leap and Lilly Enter Collaboration to Accelerate Genetic Medicine Development with AI

09/05/24, 1:31 PM
Location
https://purecatamphetamine.github.io/country-flag-icons/3x2/US.svgnew york
Money
$409 million
Industry
artificial intelligence
biotechnology
health care
Type
partnership
Genetic Leap and Eli Lilly and Company have entered a research collaboration to develop genetic medicine therapeutics using Genetic Leap's RNA-targeted AI platform. The collaboration aims to generate oligonucleotide drugs against targets selected by Lilly in high priority therapeutic areas, leveraging the potential of RNA in addressing critical diseases that traditional drugs have not effectively targeted.

Company Info

Company
Genetic Leap
Location
new york, new york, united states
Additional Info
Genetic Leap is innovating at the cutting edge of AI and RNA genetic medicine to redefine drug development and more quickly address the health needs of millions of people.